Drugs / KZ101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06866275 | Apr 2025 → Apr 2028 expected | autism spectrum disorder | Children's Hospital of Orange County | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KZ101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06866275 ↗ |
| Route | Intravenous | “repeat dosing by IV infusion” NCT06866275 ↗ |